0001209191-15-053020.txt : 20150612
0001209191-15-053020.hdr.sgml : 20150612
20150612201500
ACCESSION NUMBER: 0001209191-15-053020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150610
FILED AS OF DATE: 20150612
DATE AS OF CHANGE: 20150612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L
CENTRAL INDEX KEY: 0001202016
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 15929832
MAIL ADDRESS:
STREET 1: C/O XIMMUNOMEDICS INC
STREET 2: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN CYNTHIA L
DATE OF NAME CHANGE: 20021029
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-10
0
0000722830
IMMUNOMEDICS INC
IMMU
0001202016
GOLDENBERG CYNTHIA L
C/O IMMUNOMEDICS, INC.
300 AMERICAN ROAD
MORRIS PLAINS
NJ
07950
1
1
0
0
President and CEO
Common Stock
2015-06-10
4
M
0
15300
2.67
A
524857
D
Common Stock
2015-06-10
4
S
0
15300
4.6751
D
509557
D
Common Stock
2015-06-10
4
M
0
15120
2.67
A
5296537
I
See footnote
Common Stock
2015-06-10
4
S
0
15120
4.6745
D
5281417
I
See footnote
Common Stock
2015-06-11
4
M
0
84700
2.67
A
594257
D
Common Stock
2015-06-11
4
S
0
84700
4.3035
D
509557
D
Common Stock
2015-06-11
4
M
0
21191
1.75
A
530748
D
Common Stock
2015-06-11
4
S
0
21191
4.3035
D
509557
D
Common Stock
2015-06-11
4
M
0
93989
2.67
A
5375406
I
See footnote
Common Stock
2015-06-11
4
S
0
93989
4.3046
D
5281417
I
See footnote
Common Stock
2015-06-12
4
M
0
58512
1.75
A
568069
D
Common Stock
2015-06-12
4
S
0
58512
4.2672
D
509557
D
Common Stock
2015-06-12
4
M
0
70841
2.67
A
5352258
I
See footnote
Common Stock
2015-06-12
4
S
0
70841
4.2668
D
5281417
I
See footnote
Stock Option (right to buy)
2.67
2015-06-10
4
M
0
15300
0.00
D
2015-07-18
Common Stock, par value $0.01 per share
15300
84700
D
Stock Option (right to buy)
2.67
2015-06-10
4
M
0
15120
0.00
D
2015-07-18
Common Stock, par value $0.01 per share
15120
284880
I
See footnote
Stock Option (right to buy)
2.67
2015-06-11
4
M
0
84700
0.00
D
2015-07-18
Common Stock, par value $0.01 per share
84700
0
D
Stock Option (right to buy)
1.75
2015-06-11
4
M
0
21191
0.00
D
2015-06-15
Common Stock, par value $0.01 per share
21191
128809
D
Stock Option (right to buy)
2.67
2015-06-11
4
M
0
93989
0.00
D
2015-07-18
Common Stock, par value $0.01 per share
93989
190891
I
See footnote
Stock Option (right to buy)
1.75
2015-06-12
4
M
0
58512
0.00
D
2015-06-15
Common Stock, par value $0.01 per share
58512
70297
D
Stock Option (right to buy)
2.67
2015-06-12
4
M
0
70841
0.00
D
2015-07-18
Common Stock, par value $0.01 per share
70841
120050
I
See footnote
Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Medical Officer and Chairman of the Board of Directors.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.65 to $4.71.
The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.21 to 4.61.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.21 to 4.34.
These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan.
These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested immediately.
/s/ Cynthia L. Goldenberg
2015-06-12